granzyme E Activators
Granzyme E activators are a class of compounds that indirectly enhance the activity of granzyme E through modulation of cellular signaling pathways associated with the activation and degranulation of cytotoxic T cells and NK cells. These compounds do not directly interact with granzyme E; instead, they influence the cellular environment and signaling cascades that lead to the functional activation of this protease. For example, compounds such as Phorbol 12-myristate 13-acetate (PMA) and Bryostatin 1 activate protein kinase C (PKC), a key signaling molecule in the pathway leading to T cell activation. This activation can enhance the degranulation process, thereby increasing the release of granzyme E into the immunological synapse between cytotoxic cells and their targets.
Other compounds in this class, such as calcium ionophores (e.g., Ionomycin) and SERCA pump inhibitors (e.g., Thapsigargin), operate by altering the intracellular concentration of calcium, a critical second messenger in cellular activation. Elevated calcium levels can potentiate the signaling pathways that lead to the exocytosis of cytotoxic granules containing granzyme E. Similarly, compounds affecting intracellular pH and ion concentrations, such as Monensin, can also influence the processing and release of granzyme E.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophores like A23187 can increase intracellular calcium levels, which is a crucial second messenger in T cell activation. Elevated calcium can enhance the degranulation process of cytotoxic T cells, leading to the release of granzyme E. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is a part of the signaling cascade in T cells. Activation of PKC leads to T cell activation and may enhance the cytotoxic granule exocytosis, where granzyme E is released. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that selectively transports calcium ions across cell membranes, leading to T cell activation and subsequent enhancement of granzyme E release. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which may contribute to the regulation of T cell activation, potentially enhancing the release of granzyme E. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
As a lectin that binds to glycoproteins on the cell surface, Concanavalin A can stimulate T cells and promote the release of cytotoxic granules containing granzyme E. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Though primarily an immunosuppressant, Cyclosporin A can affect T cell activation signaling pathways. Its complex effects could theoretically lead to a state that enhances granzyme E activity. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
Similar to Cyclosporin A, FK506 affects T cell activation. While its primary use is immunosuppression, its modulation of signaling could lead to enhanced granzyme E release in certain contexts. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
This compound is a potent inhibitor of protein phosphatases 1 and 2A, leading to hyperphosphorylation of cellular proteins, which can affect multiple signaling pathways, potentially enhancing the release of granzyme E. | ||||||